Skip to content

Clinical trials

Completed Leukemia, Myelomonocytic, Chronic trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelomonocytic, Chronic Status: Completed Country / region: Australia Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20111
20131
20172
20181
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Oncology Group2
Novartis Pharmaceuticals2
Kirby Institute1
Prelude Therapeutics1
Takeda1
The Canadian Blood and Marrow Transplant Group1
Traws Pharma, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelomonocytic, Chronic9
Myelodysplastic Syndromes7
Leukemia, Myeloid, Acute4
Anemia, Refractory, with Excess of Blasts3
Leukemia3
Leukemia, Myelomonocytic, Juvenile3
Myeloproliferative Disorders3
Anemia, Refractory2
Burkitt Lymphoma2
Leukemia, Lymphocytic, Chronic, B-Cell2

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.